Mr Bourla does not say in the interview that COVID jabs are dangerous. The interview begins at the 35 seconds mark of the ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centred on text messages she exchanged with the head of vaccine maker Pfizer during negotiations for Covid jabs, her lawyer ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

While the COVID-19 pandemic is behind us, conspiracy theories, much like the virus itself, haven’t gone anywhere. And the latest bizarre claim about the vaccine is, let’s just say, a bit out of the ...